Official pages and third-party coverage in one index.
jacobscapitalgroup.com9 items across 8 mapped pages · Crawled Sep 25, 2026
Official pages and third-party coverage in one index
HealthCap V portfolio company Targovax ASA has announced a successful NOK 200 million private placement, in which HealthCap V L.P. has committed to participate with NOK 25 million. HealthCap is the largest shareholder in Targovax with 22%, fully diluted, following the private placement, but prior to the repair offering of up to an additional NOK …
Alex Suh is a founding Managing Director with California Technology Ventures, LLC, a Southern California venture capital firm that focuses its investments in the fields of Life Sciences and Information Technology. Alex is the managing director that invests in Life Sciences as well as Information Technology.
Andrea DeVita is Director of Finance at California Technology Ventures, LLC and Jacobs Capital Group, LLC. She is responsible for all financial and operational activities, as well as assisting with business plan sourcing, due diligence, special projects, and assisting portfolio companies.
William A. Hanna is a Managing Director with California Technology Ventures, LLC and Jacobs Capital Group, LLC. He brings extensive experience and expertise in the financial and investment industries to the team.
Although we are a venture capital fund of funds, we are also venture capitalists. We felt that the traditional venture capital model needed to be changed. We no longer want to assume that we can invest in companies within a single sector, invest only in our own backyard, invest only on our own, or invest only in companies that had with 10x returns.. In addition, we do not invest in companies based on the mathematical assumption of relying on a few successful companies to cover our less fortunate
We look to invest in venture funds that have a shared vision and strategically fit our overall investment principles. We do not invest in funds purely in search of alpha. We are not significant investors, but we bring a value that most fund-of-funds may not be able to which could enhance success. Unless there is a fit or benefit to our entire circle of partner funds, we may not be the right fit for you as investors. Most of the funds we have invested are funds we have worked with or have built a
